MedBio Capital

MedBio Capital is a boutique investment bank focusing on life sciences and healthcare, dedicated to become the financial and strategic partner for top-notch scientists and entrepreneurs.
The core team have been deeply involved in the medical industry for many years, covering key roles in R&D, clinical and market, and has a complex background in investment, investment banking and consulting. The team members have completed financing of more than 10 billion RMB, and have served more than ten top medical listed companies.

Financing

Private equity financing: helping growing companies raise funds, including initiating and executing private equity financing, bonds, etc.

M&A

M&A Advisory: Comprehensive sell-side and buy-side advisory services, including acquisitions, company sales, divestitures or mergers, joint venture formations and spin-offs, sound valuation advice

Consulting

Strategic consulting: help clients sort out strategic plans, and provide clients with services such as business expansion and patent transfer consulting

Asset Management

Asset management: help clients find suitable investment opportunities at home and abroad, and provide market value management services for listed companies

Willys 2022-04-03

Me than ten years of experience in marketing, investment, M&A and investment banking in the medical field.

At the end of 2020, he founded MedBio Capital and led the team to complete dozens of private equity financing projects in the fields of biomedicine, medical devices, and innovative services.

Before founded MedBioCapital, he was the head of the medical industry of Index Capital, and he was also responsible for mergers and acquisitions in the medical service sector at Hillhouse Capital. Before that, he worked for Zhongyu Capital, Becton,Dickinson and Company, and Johnson & Johnson Medical.

Master of Finance, Renmin University of China, Bachelor of Engineering, Xi'an Jiaotong University

Willys Zhai

2022-04-03

Vivienne 2022-04-09

Principal of innovative medical，Head of ECM, with many years of experience in investment banking.

Before joining MedBioCapital, she was founding member of Index Capital and has participated in the financing of more than 40+ projects, including many unicorn companies such as Linkdoc and Boss Zhipin. She has very rich transaction experience.

Bachelor of Pharmacy Fudan University

Vivienne Guo

2022-04-09

Elva Mu 2022-04-09

Principal of innovative drug sector,with nearly ten years of experience in pharmaceutical consulting and investment banking.

Before joining MedBioCapital, he was the director of Pharmacodia Consulting, providing due diligence, technical consulting, strategic consulting and other services for many well-known domestic pharmaceutical companies and investment institutions. Before that, she worked in Zhongrui Pharmaceutical Consulting, responsible for policy and industry research, and was the editor-in-chief of the "White Paper on the Pharmaceutical Industry". She also worked in Konruns Pharmaceutical, responsible for government affairs and project management.

Master of Medicine, with dual education background in basic medicine and small molecule drug synthesis

Elva Mu

2022-04-09

Huanxing 2022-04-09

Principal of Biotech sector,with more than ten years of experience in pharmaceutical R&D, investment management and investment banking.

Before joining MedBio Capital, he was a core member of Empower Capital, leading the investment in projects such as Leader of iPSC Hopstem Biotechnology. Before that, he worked in Xianju Pharmaceutical, engaged in R&D and BD.

MS and BS in Medicinal Chemistry，Lanzhou University

Huanxing Ding

2022-04-09